Deputy Chief Physician, Associate Professor, Secretary of the Surgical Teaching and Research Office, Gastrointestinal Center Ward II, Peking University Cancer Hospital & Institute; Doctor of Oncology Specialties: Radical surgery for gastrointestinal tumors, laparoscopic minimally invasive surgery, with emphasis on nerve and organ function preservation and enhanced recovery after surgery. Trained under Professor Ji Jiafu, President of the International Gastric Cancer Association, Academician of the Chinese Academy of Engineering, and renowned oncology expert in China. From 2010 to 2012, conducted basic research and clinical observation related to gastrointestinal tumors at the UCSF Medical Center in the United States. Received a Doctorate in Oncology from Peking University in 2013. Current positions: Member of the Colorectal Disease Branch of the China International Exchange and Promotive Association for Medical and Health Care, Member of the Gastrointestinal Disease Special Committee of the Beijing Chronic Disease Prevention and Health Education Research Association, Member of the Clinical Support Professional Committee of the China Medical Education Association, Corresponding Editorial Board Member of the Chinese Journal of Colorectal Diseases (Electronic Edition), and Youth Editorial Board Member of The Innovation Medicine. Principal Investigator of the National Natural Science Foundation of China Youth Project, Beijing Municipal Natural Science Foundation General Project, Peking University Clinical Medicine + X Youth Project, Peking University Cancer Hospital Internal Fund, and Key Laboratory Open Project of the Ministry of Education. Total project funding: 1.2 million RMB. Published multiple SCI papers as (co-)first author/corresponding author in top international journals such as The Journal of Clinical Investigation and Genome Biology, with a total impact factor exceeding 100. Invited to present at the UCSF Cancer Center Annual Academic Conference, the 10th and 11th International Gastric Cancer Congress, and the 13th National Gastric Cancer Conference. Co-editor of monographs including Standardized Surgery for Gastric Cancer and Standardized Surgery for Colorectal Cancer. Awarded the Peking University Innovation Award (2011–2012), Best Oral Presentation Award at the 10th International Gastric Cancer Congress, and Young Scholar Award at the 88th Annual Meeting of the Japanese Gastric Cancer Association. Recognized as Outstanding Teaching Instructor, Outstanding Specialist Training Instructor, and Advanced Individual in Teaching Management at Peking University Cancer Hospital in 2021, 2022, and 2023, respectively. Representative Publications (Last 5 Years): 1. Fan B#, Su H#, Wang L#, et al. Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial. Chin J Cancer Res. 2025 Jan 30;37(1):66-72. 2. He Q#, Huangfu L#, Fan B#, et al. T-cells infiltration mediates the association between neutrophil/lymphocyte ratio and survival in gastric cancer. Cancer Med. 2023 Aug;12(15):15893-15902. 3. Kang B#, Camps J#, Fan B#, et al. Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment. Genome Biol. 2022 Dec 22;23(1):265. 4. Huangfu L#, Fan B#, Wang G, et al. Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer. Cell Death Discov. 2022 Jan 10;8(1):5. 5. Fan B#, Ji K#, Bu Z, et al. ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Front Mol Biosci. 2021 Oct 18;8:720645. 6. Lu X, Peng B, Chen G, Pes MG, Ribback S, Ament C, Xu H, Pal R, Rodrigues PM, Banales JM, Evert M, Calvisi DF, Chen X, Fan B*, Wang J*. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice. Am J Pathol. 2021 Sep;191(9):1651-1667. 7. Fan B, Bu Z, Zhang J, et al. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer. 2021 Mar 2;21(1):216.